 Medtronic plc NYSE:MDT has agreed to acquire Intersect ENT Inc NASDAQ:XENT for 28.25 per share in an all-cash transaction implying an enterprise value of approximately 1.1 billion. Medtronics acquisition of Intersect ENT expands the companys portfolio of products used during ear, nose, and throat procedures. 